Presentation – Webcast melflufen’s mechanism of action

January 24, 2020

Oncopeptides hosted a webcast on Monday, January 27th 2020 were CEO Jakob Lindberg presented and explained melflufen’s mechanism of action. Investors, analysts and the media were invited to the webcast.

The presentation is available below.

The conference was recorded and can be viewed via this link